3-126482350-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144639.3(UROC1):c.2026C>T(p.Leu676Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,460,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144639.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UROC1 | NM_144639.3 | c.2026C>T | p.Leu676Phe | missense_variant | 20/20 | ENST00000290868.7 | NP_653240.1 | |
UROC1 | NM_001165974.2 | c.2206C>T | p.Leu736Phe | missense_variant | 21/21 | NP_001159446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UROC1 | ENST00000290868.7 | c.2026C>T | p.Leu676Phe | missense_variant | 20/20 | 1 | NM_144639.3 | ENSP00000290868.2 | ||
UROC1 | ENST00000383579.3 | c.2206C>T | p.Leu736Phe | missense_variant | 21/21 | 1 | ENSP00000373073.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248354Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134790
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460658Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726600
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.2026C>T (p.L676F) alteration is located in exon 20 (coding exon 20) of the UROC1 gene. This alteration results from a C to T substitution at nucleotide position 2026, causing the leucine (L) at amino acid position 676 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at